aspartic acid has been researched along with Cerebro-Hepato-Renal Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brockmann, K; Dechent, P; Gärtner, J; Krause, C; Ohlenbusch, A; Rosewich, H | 1 |
| Biermanns, M; Brosius, U; Gärtner, J; Preuss, N | 1 |
| Battini, R; Bianchi, MC; Boldrini, A; Cioni, G; de Vries, LS; Groenendaal, F; Tosetti, M | 1 |
3 other study(ies) available for aspartic acid and Cerebro-Hepato-Renal Syndrome
| Article | Year |
|---|---|
Diagnostic and prognostic value of in vivo proton MR spectroscopy for Zellweger syndrome spectrum patients.
Topics: Adolescent; Adult; Aspartic Acid; Basal Ganglia; Child; Dipeptides; Female; Gray Matter; Humans; Infant; Magnetic Resonance Spectroscopy; Male; Peroxisomes; Prognosis; Protons; White Matter; Young Adult; Zellweger Syndrome | 2016 |
Mutations in PEX1 in peroxisome biogenesis disorders: G843D and a mild clinical phenotype.
Topics: Aspartic Acid; ATPases Associated with Diverse Cellular Activities; Child; Glycine; Humans; Infant; Membrane Proteins; Microbodies; Mutation; Peroxisomal Disorders; Phenotype; Zellweger Syndrome | 1999 |
Proton magnetic resonance spectroscopy (1H-MRS) of the cerebrum in two young infants with Zellweger syndrome.
Topics: Aspartic Acid; Brain; Choline; Creatine; Diagnosis, Differential; Dominance, Cerebral; Energy Metabolism; Follow-Up Studies; Humans; Infant; Infant, Newborn; Lactic Acid; Lipid Metabolism; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Peroxisomal Disorders; Phosphocreatine; Reference Values; Zellweger Syndrome | 2001 |